Journal
PROTEIN SCIENCE
Volume 31, Issue 2, Pages 312-322Publisher
WILEY
DOI: 10.1002/pro.4228
Keywords
covalent drug; genetic code expansion; latent bioreactive unnatural amino acid; protein therapeutics; protein-protein interaction; proximity-enabled bioreactivity
Categories
Funding
- National Institutes of Health [R01GM118384]
Ask authors/readers for more resources
By designing latent bioreactive unnatural amino acids and genetically encoding them into proteins, the covalent bonding ability of proteins can be expanded, creating new covalent bonds within and between proteins. These bonds enhance protein properties, modulate protein function, probe protein interactions, and develop covalent protein drugs.
To expand protein's covalent bonding ability, latent bioreactive unnatural amino acids have been designed and genetically encoded into proteins, which react with specific natural amino acid residues through proximity-enabled bioreactivity. The resultant new covalent bonds can be selectively created within and between proteins in vitro, in cells, and in vivo. Offering diverse properties previously unattainable, these covalent linkages have been harnessed to enhance protein properties, to modulate protein function, to probe ligand-receptor binding, to identify elusive protein interactions, and to develop covalent protein drugs. Selective introduction of covalent bonds into proteins is affording novel avenues for biological studies, synthetic biology, and biotherapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available